Riskpilot← Back to searchSign inGet full accessSkelett och violett AB
ABActiveOrg 5591279244Vanåsgatan 47Hospital activities · NACE 8610Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
-128% vs 2023
Equity ratio
86.4%
Financial strength
Net profit 2024
SEK -14K
-135% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -14K | -128% |
| Net profit | SEK -14K | -135% |
| Total assets | SEK 72K | -41% |
| Equity | SEK 62K | -35% |
| Employees | 0 | — |
Legal name
Skelett och violett AB
Org number
5591279244
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
4 oktober 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom sjuk- och hälsovård, innefattande uthyrning av läkare på sjukhus och andra vårdinrättningar, läkarbevakning vid sport- och idrottsevenemang, friskvård, samt konsultativa, pedagogiska och utbildande uppdrag. Bolaget ska även bedriva verksamhet inom grafisk formgivning, bildkonst och blonmsterkreationer, innefattande tillverkning och försäljning av inredningsdetaljer i keramik och 3D-printat material samt odling av blommor som används i blomsterdekorationer. Bolaget får även äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Vanåsgatan 47
Email
lind.dennis@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 49 | 93 | 0 |
| Staff expenses | — | — | −2 | −1 | −0 |
| EBITDA | −11 | −11 | 27 | 50 | −14 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −11 | −11 | 27 | 50 | −14 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | −11 | −11 | 27 | 50 | −14 |
| Tax | −0 | −0 | −0 | −10 | — |
| Net profit | −11 | −11 | 27 | 40 | −14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 40 | 30 | 63 | 123 | 72 |
| Equity | 41 | 30 | 57 | 96 | 62 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 | 0 | 6 | 26 | 10 |
| Total debt | 1 | — | 6 | 26 | 10 |
EBITDA margin
-1409800.0%
This company
15.8%
Market median
-8922885% vs market
20202024
Equity ratio
86.4%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
-22.5%
This company
18.4%
Market median
-222% vs market
20202024
Net profit margin
-1401700.0%
This company
8.1%
Market median
-17305038% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DM Chief Executive Officer | Chief Executive Officer | 2022 |
FM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skelett och violett AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dennis Max Alexander Lind | Chief Executive Officer | 0 companies |
| Frida Marie Lind | Deputy Chief Executive Officer | 0 companies |